Novel Mechanism of Action for Hydralazine: Induction of Hypoxia-Inducible Factor-1 &agr;, Vascular Endothelial Growth Factor, and Angiogenesis by Inhibition of Prolyl Hydroxylases
暂无分享,去创建一个
A. Harris | H. Knowles | D. Mole | Ya-Min Tian | Ya-min Tian
[1] David R. Williams,et al. Metal binding by pharmaceuticals. Part 4. A comparative investigation of the interaction of metal ions with hydralazine, prizidilol and related compounds , 2005, Agents and Actions.
[2] Christian Frelin,et al. Hypoxia Up-regulates Prolyl Hydroxylase Activity , 2003, Journal of Biological Chemistry.
[3] R. Johnson,et al. HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes , 2003, Journal of Cell Science.
[4] R. Johnson,et al. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. , 2003, Journal of cell science.
[5] D. Henderson-smart,et al. Drugs for treatment of very high blood pressure during pregnancy. , 2013, The Cochrane database of systematic reviews.
[6] Napoleone Ferrara,et al. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. , 2002, Seminars in oncology.
[7] D. Richardson,et al. The role of iron in cell cycle progression and the proliferation of neoplastic cells. , 2002, Biochimica et biophysica acta.
[8] K. Kangawa,et al. Intravenous Adrenomedullin in Myocardial Function and Energy Metabolism in Patients After Myocardial Infarction , 2002, Journal of cardiovascular pharmacology.
[9] M. Oehler,et al. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis , 2002, Oncogene.
[10] L. Chao,et al. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury , 2001, Peptides.
[11] R. Hendel,et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. , 2001, American heart journal.
[12] M. Gassmann,et al. HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxia , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] S. McKnight,et al. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.
[14] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[15] J. M. Arbeit,et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. , 2001, Genes & development.
[16] A. Gurney,et al. Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery , 2001, British journal of pharmacology.
[17] James L. Park,et al. Heme oxygenase-1 protects against vascular constriction and proliferation , 2001, Nature Medicine.
[18] G. Semenza. Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease , 2001, Pediatric Research.
[19] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[20] V. Fuster,et al. Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist. , 2001, Archives of internal medicine.
[21] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[22] G. Taraboletti,et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 2000, The American journal of pathology.
[23] M. Noble,et al. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. , 2000, Human molecular genetics.
[24] N. Ali,et al. Activation of particulate guanylate cyclase by adrenomedullin in cultured SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells. , 2000, Cellular signalling.
[25] J. Waltenberger,et al. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. , 1999, Biochemical and biophysical research communications.
[26] P. Pagliaro,et al. New insights into nitric oxide and coronary circulation. , 1999, Life sciences.
[27] A. Latimer,et al. Activation of particulate guanylyl cyclase by endothelins in cultured SV-40 transformed cat iris sphincter smooth muscle cells. , 1998, Life sciences.
[28] W. Risau,et al. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Nielsen-Kudsk,et al. Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels. , 1998, European journal of pharmacology.
[30] K. Rehse,et al. New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivatives. , 1998, Archiv der Pharmazie.
[31] G. Semenza,et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[32] G. Semenza,et al. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[33] N. Abraham,et al. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis , 1998, Journal of cellular biochemistry.
[34] A. Choi,et al. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. , 1997, The American journal of physiology.
[35] M. Yanagisawa,et al. Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery. , 1997, European journal of pharmacology.
[36] S. Rajagopalan,et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. , 1996, The Journal of clinical investigation.
[37] U. Elkayam,et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.
[38] Y. Hirata,et al. Autocrine Regulation of the Endothelin‐1 Gene in Rat Endothelial Cells , 1995, Journal of cardiovascular pharmacology.
[39] J. Caro,et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[40] A. Logan,et al. Angiogenesis , 1993, The Lancet.
[41] N. Bleehen,et al. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice. , 1992, International journal of radiation oncology, biology, physics.
[42] E. Darwish,et al. Management of severe preeclampsia detected in early labor by prostaglandin A1 or dihydralazine infusions. , 1991, American journal of obstetrics and gynecology.
[43] R. Fisker,et al. Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues. , 1991, Acta oncologica.
[44] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .
[45] S. Pinnell,et al. A paradoxical effect of hydralazine on prolyl and lysyl hydroxylase activities in cultured human skin fibroblasts. , 1985, Archives of biochemistry and biophysics.
[46] M. Jacobs. Mechanism of action of hydralazine on vascular smooth muscle. , 1984, Biochemical pharmacology.
[47] K. Hermsmeyer,et al. Effect of hydralazine on tension and membrane potential in the rat caudal artery. , 1983, The Journal of pharmacology and experimental therapeutics.
[48] C. Desch,et al. Hydralazine and Isosorbide Dinitrate: Comparative Central and Regional Hemodynamic Effects When Administered Alone or in Combination , 1981, Circulation.
[49] P. Reece,et al. Kinetics of hydralazine and its main metabolites in slow and fast acetylators , 1980, Clinical pharmacology and therapeutics.
[50] S. Wolfe,et al. Hydralazine-induced disturbances in collagen biosynthesis. , 1972, Biochimica et biophysica acta.